vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Akso Health Group (AHG). Click either name above to swap in a different company.

ASCENT INDUSTRIES CO. is the larger business by last-quarter revenue ($11.9M vs $7.0M, roughly 1.7× Akso Health Group). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -18.6%, a 9.8% gap on every dollar of revenue.

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Akso Health Group is a global healthcare enterprise specializing in the R&D, production, and distribution of generic pharmaceuticals, over-the-counter wellness products, and medical devices. It primarily serves markets in China, Southeast Asia, and North America, with core business segments covering drug manufacturing, medical supply chains, and community healthcare services.

ACNT vs AHG — Head-to-Head

Bigger by revenue
ACNT
ACNT
1.7× larger
ACNT
$11.9M
$7.0M
AHG
Higher net margin
ACNT
ACNT
9.8% more per $
ACNT
-8.8%
-18.6%
AHG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ACNT
ACNT
AHG
AHG
Revenue
$11.9M
$7.0M
Net Profit
$-1.0M
$-1.3M
Gross Margin
14.6%
8.9%
Operating Margin
-21.0%
-20.5%
Net Margin
-8.8%
-18.6%
Revenue YoY
13.3%
Net Profit YoY
-1.2%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
AHG
AHG
Q4 25
$11.9M
Q3 25
$19.7M
$7.0M
Q2 25
$18.7M
Q1 25
$24.7M
Q4 24
$10.5M
Q3 24
$20.9M
Q2 24
$21.5M
Q1 24
$28.0M
Net Profit
ACNT
ACNT
AHG
AHG
Q4 25
$-1.0M
Q3 25
$-2.1M
$-1.3M
Q2 25
$6.3M
Q1 25
$-2.3M
Q4 24
$-1.0M
Q3 24
$-6.2M
Q2 24
$-926.0K
Q1 24
$-5.5M
Gross Margin
ACNT
ACNT
AHG
AHG
Q4 25
14.6%
Q3 25
29.7%
8.9%
Q2 25
26.1%
Q1 25
19.3%
Q4 24
24.3%
Q3 24
14.4%
Q2 24
13.1%
Q1 24
8.3%
Operating Margin
ACNT
ACNT
AHG
AHG
Q4 25
-21.0%
Q3 25
-4.1%
-20.5%
Q2 25
-14.4%
Q1 25
-4.2%
Q4 24
-25.4%
Q3 24
-9.4%
Q2 24
-8.6%
Q1 24
-15.5%
Net Margin
ACNT
ACNT
AHG
AHG
Q4 25
-8.8%
Q3 25
-10.6%
-18.6%
Q2 25
33.7%
Q1 25
-9.3%
Q4 24
-9.8%
Q3 24
-29.5%
Q2 24
-4.3%
Q1 24
-19.7%
EPS (diluted)
ACNT
ACNT
AHG
AHG
Q4 25
$-0.11
Q3 25
$-0.22
Q2 25
$0.65
Q1 25
$-0.23
Q4 24
$-0.11
Q3 24
$-0.61
Q2 24
$-0.09
Q1 24
$-0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
AHG
AHG
Cash + ST InvestmentsLiquidity on hand
$57.6M
$11.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.0M
$198.3M
Total Assets
$111.9M
$212.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
AHG
AHG
Q4 25
$57.6M
Q3 25
$58.0M
$11.1M
Q2 25
$60.5M
Q1 25
$14.3M
Q4 24
$16.1M
Q3 24
$8.5M
Q2 24
$3.6M
Q1 24
$1.3M
Total Debt
ACNT
ACNT
AHG
AHG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
AHG
AHG
Q4 25
$87.0M
Q3 25
$87.1M
$198.3M
Q2 25
$89.7M
Q1 25
$91.2M
Q4 24
$93.5M
Q3 24
$94.7M
Q2 24
$101.0M
Q1 24
$102.0M
Total Assets
ACNT
ACNT
AHG
AHG
Q4 25
$111.9M
Q3 25
$119.9M
$212.0M
Q2 25
$122.6M
Q1 25
$152.5M
Q4 24
$147.3M
Q3 24
$148.6M
Q2 24
$158.2M
Q1 24
$161.0M
Debt / Equity
ACNT
ACNT
AHG
AHG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
AHG
AHG
Operating Cash FlowLast quarter
$266.0K
$1.2M
Free Cash FlowOCF − Capex
$-196.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
AHG
AHG
Q4 25
$266.0K
Q3 25
$1.3M
$1.2M
Q2 25
$-1.4M
Q1 25
$-700.0K
Q4 24
$8.8M
Q3 24
$3.4M
Q2 24
$2.2M
Q1 24
$263.0K
Free Cash Flow
ACNT
ACNT
AHG
AHG
Q4 25
$-196.0K
Q3 25
$695.0K
Q2 25
$-1.5M
Q1 25
$-1.0M
Q4 24
$8.4M
Q3 24
$3.1M
Q2 24
$1.9M
Q1 24
$25.0K
FCF Margin
ACNT
ACNT
AHG
AHG
Q4 25
-1.7%
Q3 25
3.5%
Q2 25
-8.3%
Q1 25
-4.1%
Q4 24
80.6%
Q3 24
15.1%
Q2 24
9.1%
Q1 24
0.1%
Capex Intensity
ACNT
ACNT
AHG
AHG
Q4 25
3.9%
Q3 25
3.1%
Q2 25
0.8%
Q1 25
1.3%
Q4 24
3.7%
Q3 24
1.3%
Q2 24
1.0%
Q1 24
0.9%
Cash Conversion
ACNT
ACNT
AHG
AHG
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

AHG
AHG

Segment breakdown not available.

Related Comparisons